Abstract

New Insights on Ovarian Cancer Biomarker CA125

Rebecca Whelan, Associate Professor of Chemistry, University of Kansas

Through a combination of long-read sequencing, proteomics, and mutation analysis, the Whelan lab has recently developed a new model for the ovarian cancer biomarker CA125. These results and remaining questions will be presented.

Add to Calendar ▼2024-03-18 00:00:002024-03-19 00:00:00Europe/LondonEmerging Technologies and Paradigms for In Vitro Dx Europe 2024Emerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors